Establishment of the Board of Scientific Counselors, Division of Translational Toxicology, National Institute of Environmental Health Sciences, 80321 [2023-25472]

Download as PDF Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// acd.od.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: November 13, 2023. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–25376 Filed 11–16–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, November 17, 2023, 10:00 a.m. to 04:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the Federal Register on November 3, 2023, 88 FR 77102. This notice is being amended to change this one-day meeting from November 17, 2023, to November 27, 2023. The meeting time remains the same. The meeting is closed to the public. VerDate Sep<11>2014 18:57 Nov 16, 2023 Jkt 262001 80321 Dated: November 13, 2023. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2023–25404 Filed 11–16–23; 8:45 am] National Center for Advancing Translational Sciences; Notice of Closed Meetings BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Establishment of the Board of Scientific Counselors, Division of Translational Toxicology, National Institute of Environmental Health Sciences Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. 1001–1014), the Director, National Institutes of Health (NIH) announces the establishment of the Board of Scientific Counselors, Division of Translational Toxicology, National Institute of Environmental Health Sciences, as authorized by 42 U.S.C. 282(b)(16), section 402(b)(16) of the Public Health Service Act, as amended. The Director, NIH, has determined that the Board of Scientific Counselors, Division of Translational Toxicology, National Institute of Environmental Health Sciences is in the public interest in connection with the performance of duties imposed on NIH by law, and that these duties can best be performed through the advice and counsel of the committee. The committee will review and evaluate the intramural program and the work of tenured, tenure track, and staff scientists and physicians and shall also, as requested by the Director, NIH, undertake peer review of extramural funding applications as required by section 492 of the Public Health Service Act, as amended. Inquiries may be directed to Claire Harris, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail code 4875), Telephone (301) 496– 2123, or Claire.Harris@nih.gov. Dated: November 13, 2023. Monica M. Bertagnolli, Director, National Institutes of Health. [FR Doc. 2023–25472 Filed 11–16–23; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 National Institutes of Health Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; CTSA Collaborative and Innovative Acceleration Awards. Date: February 7, 2024. Time: 11:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1068, Bethesda, MD 20892, (301) 435–0810, lourdes.ponce@nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Understudied Proteins Associated with Rare Diseases (R03) Review. Date: February 29, 2024. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ming Yan, MD, Ph.D. Scientific Review Officer Scientific Review Branch Division of Extramural Activities National Center for Advancing Translational Sciences 6701 Democracy Boulevard, MSC 4874 Bethesda, MD 20892 (301) 827–4312 ming.yan@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) E:\FR\FM\17NON1.SGM 17NON1

Agencies

[Federal Register Volume 88, Number 221 (Friday, November 17, 2023)]
[Notices]
[Page 80321]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25472]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Establishment of the Board of Scientific Counselors, Division of 
Translational Toxicology, National Institute of Environmental Health 
Sciences

    Pursuant to the Federal Advisory Committee Act, as amended (5 
U.S.C. 1001-1014), the Director, National Institutes of Health (NIH) 
announces the establishment of the Board of Scientific Counselors, 
Division of Translational Toxicology, National Institute of 
Environmental Health Sciences, as authorized by 42 U.S.C. 282(b)(16), 
section 402(b)(16) of the Public Health Service Act, as amended.
    The Director, NIH, has determined that the Board of Scientific 
Counselors, Division of Translational Toxicology, National Institute of 
Environmental Health Sciences is in the public interest in connection 
with the performance of duties imposed on NIH by law, and that these 
duties can best be performed through the advice and counsel of the 
committee.
    The committee will review and evaluate the intramural program and 
the work of tenured, tenure track, and staff scientists and physicians 
and shall also, as requested by the Director, NIH, undertake peer 
review of extramural funding applications as required by section 492 of 
the Public Health Service Act, as amended.
    Inquiries may be directed to Claire Harris, Director, Office of 
Federal Advisory Committee Policy, Office of the Director, National 
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, 
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or 
[email protected].

    Dated: November 13, 2023.
Monica M. Bertagnolli,
Director, National Institutes of Health.
[FR Doc. 2023-25472 Filed 11-16-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.